申请人:TAISHO PHARMACEUTICAL CO., LTD.
公开号:US20210070747A1
公开(公告)日:2021-03-11
Provided are: useful novel compounds that exhibit antibacterial activity based on their actions for inhibiting GyrB of DNA gyrase and ParE of topoisomerase IV; and 2(1H)-quinolinone derivatives represented by formula [1]:
or pharmaceutically acceptable salts thereof.